Comparison of Prophylactic Antiemetic Effects of Ondansetron Versus Haloperidol in Patients Undergoing Mastectomy: A Double-Blind Randomized Trial
Open Access
- 28 July 2025
- journal article
- Published by Brieflands in Journal of Cellular & Molecular Anesthesia
- Vol. 10 (3)
Abstract
Background: Postoperative nausea and vomiting (PONV) is one of the most common complaints after surgery and anesthesia, and it is considered a risk factor after mastectomy. Given these findings, preventing PONV in patients undergoing various surgical procedures is of great importance. Objectives: The present study aimed to compare the preventive effects of haloperidol and ondansetron on PONV in transgender patients undergoing bilateral mastectomy. Methods: This randomized, double-blind clinical trial evaluated the effectiveness of haloperidol (2 mg IV) versus ondansetron (4 mg IV) in managing PONV in patients aged 18 to 65 years with ASA classifications of 1 or 2. Patients were monitored for vital signs and received compensatory fluids postoperatively. The severity of nausea and vomiting was assessed using a Visual Analog Scale (VAS) at multiple time points: Recovery, 0.5 hours, 1 hour, 2 hours, 6 hours, and 24 hours post-surgery. Results: No significant difference was observed in the mean age between the haloperidol (26.68 ± 4.65 years) and ondansetron (27.24 ± 4.15 years) groups (P = 0.65). At none of the postoperative assessment time points (30 minutes, 1 hour, 2 hours, 6 hours, and 24 hours) was there a statistically significant difference in the incidence of PONV between the two groups. Conclusions: In conclusion, there were no significant differences in effectiveness between haloperidol and ondansetron for managing PONV at various time points after surgery. Both medications are equally effective, so physicians should choose based on patient characteristics, surgery type, and timing of administration.Keywords
This publication has 44 references indexed in Scilit:
- Anesthetic and Analgesic Adjunctive Drugs2024
- A Postoperative Nausea and Vomiting UpdateAdvances in Anesthesia, 2023
- Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled TrialAnnals of Emergency Medicine, 2021
- Interventions for treating hyperemesis gravidarumCochrane Database of Systematic Reviews, 2016
- Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy‐Induced Nausea and Vomiting in Children With CancerPediatric Blood & Cancer, 2016
- Comparison of Dexamethasone with Ondansetron or Haloperidol for Prevention of Patient‐Controlled Analgesia‐Related Postoperative Nausea and Vomiting: A Randomized Clinical TrialWorld Journal of Surgery, 2012
- Haloperidol Dosing Strategies in the Treatment of Delirium in the Critically-IllNeurocritical Care, 2011
- Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomitingCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2007
- Ondansetron, metoclopramid, dexamethason, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized studySurgical Endoscopy, 2006
- The efficacy of ginger for the prevention of postoperative nausea and vomiting: A meta-analysisAmerican Journal of Obstetrics and Gynecology, 2006